SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001493152-19-007594
Filing Date
2019-05-16
Accepted
2019-05-16 06:11:28
Documents
13
Period of Report
2019-05-06

Document Format Files

Seq Description Document Type Size
1 form6-ka.htm 6-K/A 18715
2 ex99-1.htm EX-99.1 465799
3 ex99-1_001.jpg GRAPHIC 163602
4 ex99-1_002.jpg GRAPHIC 159984
5 ex99-1_003.jpg GRAPHIC 128233
6 ex99-1_004.jpg GRAPHIC 135129
7 ex99-1_005.jpg GRAPHIC 150403
8 ex99-1_006.jpg GRAPHIC 92079
9 ex99-1_007.jpg GRAPHIC 85862
10 ex99-1_008.jpg GRAPHIC 285585
11 ex99-1_009.jpg GRAPHIC 254006
12 ex99-1_010.jpg GRAPHIC 290953
13 ex99-1_011.jpg GRAPHIC 256792
  Complete submission text file 0001493152-19-007594.txt   3244567
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-38396 | Film No.: 19830504
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1